PT Bundamedik Tbk

Jakarta Stock Exchange BMHS.JK

PT Bundamedik Tbk Price to Earnings Ratio (P/E) on January 14, 2025: 267.47

PT Bundamedik Tbk Price to Earnings Ratio (P/E) is 267.47 on January 14, 2025, a -23.01% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

PT Bundamedik Tbk 52-week high Price to Earnings Ratio (P/E) is 408.73 on March 15, 2024, which is 52.81% above the current Price to Earnings Ratio (P/E).
PT Bundamedik Tbk 52-week low Price to Earnings Ratio (P/E) is 255.38 on December 19, 2024, which is -4.52% below the current Price to Earnings Ratio (P/E).
PT Bundamedik Tbk average Price to Earnings Ratio (P/E) for the last 52 weeks is 329.57.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Jakarta Stock Exchange: BMHS.JK

PT Bundamedik Tbk

CEO	Mr. Agus Heru Darjono
IPO Date	July 6, 2021
Location	Indonesia
Headquarters	Jl. Teuku Cik Ditiro No.28
Employees	1,434
Sector	Health Care
Industries Hospitals & Clinics

Description

PT Bundamedik Tbk provides health care services in Indonesia. As of December 31, 2021, the company operated 2 maternal and child hospitals, 3 general hospitals, 2 clinics, 10 IVF clinics, and 14 diagnostic laboratories. It also engages in the distribution of drugs, pharmaceuticals, and medical devices; and hotel, medical tourism, and management consulting businesses. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Bunda Medik is a subsidiary of PT Bunda Investama Indonesia.

Key trends

Past 5 years